Sanofi (SNY) Non-cash Items (2009 - 2025)

Sanofi has disclosed Non-cash Items across 17 years of filings, most recently posting $4.5 billion for Q2 2025.

• Non-cash Items for Q2 2025 came in at $4.5 billion, up 15.95% year-over-year; the trailing twelve-month figure through Jun 2025 was $4.5 billion (up 15.95% YoY), and the FY2023 annual result was $10.3 billion, down 13.25% from the prior year.
• Non-cash Items came in at $4.5 billion for Q2 2025 at Sanofi, up from $3.9 billion in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $11.5 billion in Q4 2022 to a low of $3.9 billion in Q2 2024.
• The 5-year median for Non-cash Items is $5.1 billion (2021), against an average of $6.9 billion.
• Across the five-year window, Non-cash Items jumped 18949.42% in 2021 and retreated 18.57% in 2024, its largest moves.
• Sanofi's Non-cash Items stood at $10.4 billion in 2021, then increased by 9.93% to $11.5 billion in 2022, then slipped by 10.87% to $10.2 billion in 2023, then plunged by 61.96% to $3.9 billion in 2024, then gained by 15.95% to $4.5 billion in 2025.
• The last three Non-cash Items figures came in at $4.5 billion (Q2 2025), $3.9 billion (Q2 2024), and $10.2 billion (Q4 2023), per Business Quant data.